Moderate To Severe Chronic Hand Eczema clinical trials

Explore recruiting moderate to severe chronic hand eczema clinical trials.

Also recruiting in Europe

Moderate To Severe Chronic Hand Eczema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Abrocitinib in Subjects with Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Moderate To Severe Chronic Hand Eczema trials by city

Moderate To Severe Chronic Hand Eczema in Toronto Moderate To Severe Chronic Hand Eczema in Vancouver Moderate To Severe Chronic Hand Eczema in Montreal Moderate To Severe Chronic Hand Eczema in Calgary Moderate To Severe Chronic Hand Eczema in Edmonton Moderate To Severe Chronic Hand Eczema in Ottawa Moderate To Severe Chronic Hand Eczema in Winnipeg Moderate To Severe Chronic Hand Eczema in Quebec City Moderate To Severe Chronic Hand Eczema in Hamilton Moderate To Severe Chronic Hand Eczema in Kitchener Moderate To Severe Chronic Hand Eczema in London Moderate To Severe Chronic Hand Eczema in Halifax Moderate To Severe Chronic Hand Eczema in New York Moderate To Severe Chronic Hand Eczema in Los Angeles Moderate To Severe Chronic Hand Eczema in Chicago Moderate To Severe Chronic Hand Eczema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease